Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 6
224
Views
11
CrossRef citations to date
0
Altmetric
Short Communications

Apigenin prevents gamma radiation-induced gastrointestinal damages by modulating inflammatory and apoptotic signalling mediators

ORCID Icon, ORCID Icon, &
Pages 1631-1635 | Received 02 Dec 2020, Accepted 17 Feb 2021, Published online: 05 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (10)

África Fernández Forné, María Jesús García Anaya, Salvador José Segado Guillot, Isaac Plaza Andrade, Lourdes de la Peña Fernández, María Jesús Lorca Ocón, Yolanda Lupiáñez Pérez, María Isabel Queipo-Ortuño & Jaime Gómez-Millán. (2023) Influence of the microbiome on radiotherapy-induced oral mucositis and its management: A comprehensive review. Oral Oncology 144, pages 106488.
Crossref
Yi Zhang, Ying Huang, Zheng Li, Hanyou Wu, Bingwen Zou & Yong Xu. (2023) Exploring Natural Products as Radioprotective Agents for Cancer Therapy: Mechanisms, Challenges, and Opportunities. Cancers 15:14, pages 3585.
Crossref
Shamprasad Varija Raghu, Suresh Rao, Venkataramana Kini, Avinash Kundadka Kudva, Thomas George & Manjeshwar Shrinath Baliga. (2023) Fruits and their phytochemicals in mitigating the ill effects of ionizing radiation: review on the existing scientific evidence and way forward. Food & Function 14:3, pages 1290-1319.
Crossref
Jun Huang, Xuedong Chen, Zaoshang Chang, Chuli Xiao & Masoud Najafi. (2023) Boosting Anti-tumour Immunity Using Adjuvant Apigenin. Anti-Cancer Agents in Medicinal Chemistry 23:3, pages 266-277.
Crossref
Masoud Moslehi, Sepideh Rezaei, Pourya Talebzadeh, Mohammad Javed Ansari, Mohammed Abed Jawad, Abduladheem Turki Jalil, Nima Rastegar‐Pouyani, Emad Jafarzadeh, Shahram Taeb & Masoud Najafi. (2022) Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms. Clinical and Experimental Pharmacology and Physiology 50:1, pages 3-18.
Crossref
Minghui Xiu, Yixuan Wang, Dan Yang, Xueyan Zhang, Yuting Dai, Yongqi Liu, Xingyao Lin, Botong Li & Jianzheng He. (2022) Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease. Frontiers in Pharmacology 13.
Crossref
Caiyun Yu, Dong Wang, Zaibin Yang & Tian Wang. (2022) Pharmacological Effects of Polyphenol Phytochemicals on the Intestinal Inflammation via Targeting TLR4/NF-κB Signaling Pathway. International Journal of Molecular Sciences 23:13, pages 6939.
Crossref
Bimal Prasad Jit, Biswajita Pradhan, Rutumbara Dash, Prajna Paramita Bhuyan, Chhandashree Behera, Rajendra Kumar Behera, Ashok Sharma, Miguel Alcaraz & Mrutyunjay Jena. (2021) Phytochemicals: Potential Therapeutic Modulators of Radiation Induced Signaling Pathways. Antioxidants 11:1, pages 49.
Crossref
Yuichi Nishiyama, Akinori Morita, Shogo Tatsuta, Misaki Kanamaru, Masahiro Sakaue, Kenta Ueda, Manami Shono, Rie Fujita, Bing Wang, Yoshio Hosoi, Shin Aoki & Takeshi Sugai. (2021) Isorhamnetin Promotes 53BP1 Recruitment through the Enhancement of ATM Phosphorylation and Protects Mice from Radiation Gastrointestinal Syndrome. Genes 12:10, pages 1514.
Crossref
Shadab Faramarzi, Simona Piccolella, Lorenzo Manti & Severina Pacifico. (2021) Could Polyphenols Really Be a Good Radioprotective Strategy?. Molecules 26:16, pages 4969.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.